Address
13 Brook Hill
Western Bank
Sheffield, South Yorkshire
S3 7TN, United Kingdom
Contact
Michael Murray+44 (0)7557 805935
michael.murray@metallobio.com
Website
Novel ruthenium antimicrobial compounds.
Through exploitation of new chemical space, two antimicrobial complexes have been developed.
High activities on priority pathogens, antimicrobial efficacy and low toxicity in-vivo and ex-vivo. Low emergence of resistance and a novel target.
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Academia
- Company
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- CARB-X
- FIND
- GARDP
- REPAIR
- OTHER / NA
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- North America
- South America
- Eurasia
- Africa
- Oceania
We would like a partner to advise and assist on the next stages of our pre-clinical development plan.
Metallobio are a prospective spin out company from the University of Sheffield developing two novel antimicrobial compounds.
N/A
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!